China Universal Asset Management »

Denali Therapeutics shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $548k 27k 20.52
2023-12-31 $343k 16k 21.46
2023-09-30 $73k 3.5k 20.63
2023-06-30 $53k 1.8k 29.51
2023-03-31 $43k 1.9k 23.04
2022-12-31 $38k 1.4k 27.81
2022-09-30 $35k 1.2k 30.30

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms Inc-class A Common Stock (META)
Vertex Pharmaceuticals Common Stock (VRTX)
Amgen Common Stock (AMGN)
Servicenow Common Stock (NOW)
Gilead Sciences Common Stock (GILD)
Regeneron Pharmaceuticals Common Stock (REGN)
Alphabet Inc-cl A Common Stock (GOOGL)
Adobe Common Stock (ADBE)
Broadcom Common Stock (AVGO)
Visa Inc-class A Shares Common Stock (V)
Apple Common Stock (AAPL)
Uber Technologies Common Stock (UBER)

View all positions for China Universal Asset Management

Top funds holding Denali Therapeutics

Baillie Gifford & Co
BlackRock
Vanguard Group
Wellington Management Company
Crestline Management
Baker Bros. Advisors
Geode Capital Management
Marshall Wace
Bank of New York Mellon
T. Rowe Price Associates
Credit Suisse
Citadel Advisors
Flagship Ventures Management
Federated Investors
Dimensional Fund Advisors

View all funds holding Denali Therapeutics